Treatment of first tonic-clonic seizure does not affect mortality: long-term follow-up of a randomised clinical trial

Salvatore Mazza, Ma Leone, R Vallalta, A Solari, E Beghi, Group First

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

14 Citazioni (Scopus)

Abstract

1. J Neurol Neurosurg Psychiatry. 2011 Aug;82(8):924-7. Epub 2011 Apr 28. Treatment of first tonic-clonic seizure does not affect mortality: long-term follow-up of a randomised clinical trial. Leone MA, Vallalta R, Solari A, Beghi E; FIRST Group. Collaborators: Hauser WA, Fratiglioni L, Bogliun G, Del Felice A, Aloisi P, Marelli A, Porto C, Fusi L, Francesconi C, Gambaro P, Basso P, Freschi R, Meregalli S, Boati E, Mamoli A, Gavalotti B, Camerlingo M, Rottoli MR, Bottacchi E, Carenini L, Sironi L, Casara GL, Vecchi M, Covezzi E, Tortorici G, Franzoni E, Marchiani V, Moscano F, Giuliani G, Angeleri VA, Polonara S, Terziani S, Quattrini A, Ortenzi A, Paggi A, Iemolo F, Geda C, Ferrari GF, Binetti MA, Martini A, Perenchio MT, Malvezzi L, Tabladon G, Severi S, Zolo P, Montano V, Fassio F, Vignolo L, Pasolini MP, Antonini L, De Maria G, Rossi G, Tonini C, Cittani D, Zagnoni PG, Clerici D, Romeo A, Viri M, Lodi M, Mazza S, Vaccario ML, De Mattei M, Cremo R, Zaina P, Gentile S, Lovera N, Piazza D, Ravetti C, Cavestro C, Rosettani P. SCDU Neurologia, AOU Maggiore della Carità, C.so Mazzini 18, 28100 Novara, Italy. maurizio.leone@maggioreosp.novara.it Comment in J Neurol Neurosurg Psychiatry. 2011 Aug;82(8):829. BACKGROUND: Information on the effects of early treatment of seizures on mortality is scarce. The authors assessed the survival of patients with a first generalised tonic-clonic seizure, randomised to immediate treatment (treated) versus treatment only in the event of seizure recurrence (untreated), over a 20-year period. METHODS: The authors followed 419 patients. The median follow-up was 19.7 years (range 0.2-21.5) for a total of 7867 person-years. RESULTS: 40 persons (9.6%) died during follow-up, 19 (8.9%) treated and 21 (10.3.%) untreated. The probability of surviving was 100% at 1 year, 97% (95% CI 95% to 99%) at 5 years, 94% (91-97) at 10 years and 91% (87-95) at 20 years in treated patients and 100%, 98% (95-100), 97% (94-99) and 89% (85-94), respectively, in untreated patients (p=0.7). After adjustment for treatment of first seizure and putative risk factors (gender, age, seizure type, previous uncertain seizures, family history of seizures, pre-, peri- and postnatal risk factors, remote aetiological factors for epilepsy, abnormal neurological examination, CT or MRI abnormalities, EEG abnormalities and acute treatment), only the presence of aetiological factors for epilepsy predicted a higher mortality (HR 3.4, 95% CI 2.5 to 4.3%; p<0.01). Patients with remote aetiological factors and who did not achieve 5-year remission had the poorest survival. CONCLUSION: Starting antiepileptic treatment immediately after the first generalised tonic-clonic seizure or only after seizure recurrence did not affect survival over the following 20 years. PMID: 21531706 [PubMed - indexed for MEDLINE]
Lingua originaleEnglish
pagine (da-a)924-927
Numero di pagine4
RivistaJOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY
Volume82
Stato di pubblicazionePubblicato - 2011

Keywords

  • first tonic-clonic seizure
  • mortality
  • treatment

Fingerprint Entra nei temi di ricerca di 'Treatment of first tonic-clonic seizure does not affect mortality: long-term follow-up of a randomised clinical trial'. Insieme formano una fingerprint unica.

Cita questo